Michael T. Sweeney
Direttore Tecnico/Scientifico/R&S presso RESVERLOGIX CORP.
Patrimonio netto: 5 902 $ in data 30/06/2024
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Donald McCaffrey | M | - | 24 anni | |
| Douglas Lankler | M | 58 | 25 anni | |
| Kenneth Zuerblis | M | 64 | 14 anni | |
| Kelly McNeill | M | 54 | 15 anni | |
| Ewelina Kulikowski | M | - | 19 anni | |
| Siu Lun To | M | 55 | - | |
| Anthony Cann | M | 76 | 15 anni | |
| François-Maurice Garnier | M | 62 | 21 anni | |
| Suneet Varma | M | 55 | 23 anni | |
| Payal Sahni Becher | F | - | 27 anni | |
| Mike McDermott | M | 58 | 21 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Jeffrey Kindler | M | 68 | 8 anni | |
| Henry McKinnell | M | 81 | 8 anni | |
| James Schoeneck | M | 66 |
Assertio Therapeutics, Inc.
 Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | 10 anni |
| George A. Lorch | M | 82 | 15 anni | |
| Craig R. Smith | M | 77 |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | 9 anni |
| Julian N. Stern | M | 99 |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | 18 anni |
| August Moretti | M | 73 |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | 6 anni |
| Peter Johann | M | 67 | 7 anni | |
| Everett Cunningham | M | 57 | 9 anni | |
| Martin MacKay | M | 68 | 14 anni | |
| Olivier Brandicourt | M | 68 | 13 anni | |
| Paul Moon | M | - | - | |
| Jonathan Emms | M | - | 20 anni | |
| Gerd Kochendoerfer | M | 56 |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | - |
| Christopher Chai | M | 58 |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | 8 anni |
| Norman Wong | M | - | 22 anni | |
| Eldon Smith | M | 84 | 9 anni | |
| Vicente J. Anido | M | 71 |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | 3 anni |
| Joseph M. Danis | M | - | 10 anni | |
| Paul Fitzhenry | M | 64 | 4 anni | |
| Jennifer Schroeder | F | - | 20 anni | |
| Jeff P. Coon | M | 61 |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | 6 anni |
| Dana George Mead | M | 88 | 12 anni | |
| George Milne | M | 80 | 32 anni | |
| Peter Corr | M | 76 | 6 anni | |
| Robert N. Burt | M | 86 | 11 anni | |
| Karen Dawes | F | 72 |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | - |
| Michael R. Jirousek | M | 65 | 5 anni | |
| Michael Brown | M | 83 | 16 anni | |
| Alexandra Kropotova | M | 51 | 5 anni | |
| Wyllie Cornwell | M | 76 | 23 anni | |
| Norma Biln | F | - | - | |
| Franklin Raines | M | 74 | 11 anni | |
| William Herbert Gray | M | 82 | 13 anni | |
| Louis Lavigne | M | 75 |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | 6 anni |
| Dawn Rogers | F | 59 | - | |
| Mark J. Taisey | M | - | 5 anni | |
| Eduardo Von Pervieux | M | - | 6 anni | |
| Fei He | M | 55 | 7 anni | |
| Christopher Scully | M | 53 | 20 anni | |
| Richard Paulson | M | 56 | 9 anni | |
| David DeMicco | M | - | 22 anni | |
| David Simmons | M | 59 | 16 anni | |
| Adrian Otte | M | - | 6 anni | |
| Muriel Cottard | M | - | 4 anni | |
| Joseph Monahan | M | 69 | 7 anni | |
| David J. Wustrow | M | 65 | 2 anni | |
| Feng Guo | M | 54 | 11 anni | |
| Deborah Baron | F | 55 | - | |
| Mariano García-Valiño | M | 58 | 8 anni | |
| Paulash Mohsen | M | - | 14 anni | |
| Alexander Polinsky | M | 67 | 8 anni | |
| Bruce Curtis Crosby | M | - | 2 anni | |
| Michael Bruce | M | - | 12 anni | |
| Baiyong Li | M | 56 | 12 anni | |
| John Chapman | M | 70 | 4 anni | |
| Hua Gong | M | 57 | 10 anni | |
| Howard Donnelly | M | 63 | 9 anni | |
| Jeffrey Ives | M | 73 | 8 anni | |
| Richard G. Minicus | M | - | - | |
| John W. Poyhonen | M | 64 | 7 anni | |
| James L. Freddo | M | 69 | 3 anni | |
| Louis Yu | M | 73 |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | 1 anni |
| Lisa Ricciardi | F | 64 | - | |
| Walter S. Hauck | M | 64 | 13 anni | |
| Lance Berman | M | 53 | 6 anni | |
| Kenneth Bahrt | M | 71 | 4 anni | |
| Ken Keyong Ren | M | 64 | 2 anni | |
| Claus Egstrand | M | 63 | 3 anni | |
| John F. Niblack | M | 85 | 35 anni | |
| William R. Howell | M | 88 | 9 anni | |
| Jonathan R. McGrath | M | - | 5 anni | |
| Robert Zerbe | M | 73 | 7 anni | |
| William Sigmund | M | - | 4 anni | |
| Kathleen Boziwick | F | - | - | |
| Linda Armstrong | M | 61 | 6 anni | |
| Brian Goldberg | M | 50 | 2 anni | |
| James New | M | 70 | 5 anni | |
| William H. D. Horton | M | - | 1 anni | |
| Victor Micati | M | 83 | 34 anni | |
| Warren R. Winter | M | - | 15 anni | |
| Gary Seelhorst | M | 52 | 8 anni | |
| Frank Sciavolino | M | 83 | 35 anni | |
| Julie A. Olson | M | - | 19 anni | |
| Eliot Forster | M | 58 | 11 anni | |
| William J. Slichenmyer | M | 66 | 7 anni | |
| Jay T. Goodwin | M | - | - | |
| Tim Bertram | M | 68 | 5 anni | |
| Michael Loechel | M | - | 11 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 89 | 89.00% |
| Canada | 11 | 11.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Michael T. Sweeney
- Contatti personali
